Leveraging nitrogen occurrence in approved drugs to identify structural patterns.

Area of Science:

• Medicinal Chemistry
• Drug Discovery
• Computational Chemistry

Background:

• Drug discovery is expensive and time-consuming.
• Minimizing synthesis-testing cycles is key.
• Analyzing heteroatoms like nitrogen aids drug design.

Purpose of the Study:

• To analyze the frequency, distribution, and diversity of nitrogen atoms in approved drugs.
• To understand the role of different nitrogen atom types (sp3, sp2, sp, planar, ring, non-ring) in drug molecules.

Main Methods:

• Examined a dataset of 2,049 small molecules approved by regulatory agencies.
• Investigated nitrogen atom types and their positions relative to the center of mass.

Main Results:

• Identified known and novel patterns in nitrogen atom distribution within drug molecules.
• Observed that most drugs contain 1-3 nitrogen atoms within 5Å of the center of mass.

Conclusions:

• Ring and planar nitrogen atoms are preferred in drug design.
• These findings provide guidance for optimizing drug candidates.
• Understanding nitrogen atom trends accelerates the conversion of lead compounds into potential drugs.